Maehara S, Sumi H, Toki N
Enzyme. 1981;26(3):122-8. doi: 10.1159/000459161.
Antisera against purified urinary trypsin inhibitor (UTI-I, molecular weight 67,000) and UTI-III (molecular weight 23,000) were first produced in rabbits. Both anti-UTI-I and anti-UTI-III sera formed a single immunoprecipitin line with human plasma inter-alpha-trypsin inhibitor (I alpha TI), whereas two immunoprecipitin lines were formed with crude urine. It was speculated that both UTI-I and UTI-II might be present in normal human urine. In the present study, the inhibitory effects of anti-UTI sera on UTI activity were examined by three different assay methods. The results indicated that the inhibitory effect was almost immediate. Although the inhibitory effect of anti-UTI-III serum on UTI-III was almost of the same degree of completeness for the three assay methods. UTI-I was partially inhibited by the anti-UTI-I serum when residual trypsin activity was measured by the caseinolytic or fibrinolytic assay method. This discrepancy was considered to be due to the difference in conformational change between UTI-I and UTI-III by antigen-antibody reaction.
针对纯化的尿胰蛋白酶抑制剂(UTI-I,分子量67,000)和UTI-III(分子量23,000)的抗血清首先在兔体内产生。抗UTI-I血清和抗UTI-III血清与人血浆间α-胰蛋白酶抑制剂(IαTI)均形成单一免疫沉淀线,而与粗尿形成两条免疫沉淀线。据推测,UTI-I和UTI-II可能都存在于正常人尿液中。在本研究中,通过三种不同的测定方法检测了抗UTI血清对UTI活性的抑制作用。结果表明抑制作用几乎是即时的。尽管抗UTI-III血清对UTI-III的抑制作用在三种测定方法中几乎具有相同程度的完全性。当通过酪蛋白溶解或纤维蛋白溶解测定方法测量残留胰蛋白酶活性时,UTI-I被抗UTI-I血清部分抑制。这种差异被认为是由于抗原-抗体反应导致UTI-I和UTI-III构象变化的差异。